Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
South Korea flag South Korea · Delayed Price · Currency is KRW
38,000
+950 (2.56%)
Jul 16, 2025, 11:38 AM KST

Mezzion Pharma Revenue

Mezzion Pharma had revenue of 1.95B KRW in the quarter ending March 31, 2025, a decrease of -9.48%. This brings the company's revenue in the last twelve months to 8.41B, down -67.78% year-over-year. In the year 2024, Mezzion Pharma had annual revenue of 8.61B, down -72.85%.

Revenue (ttm)
8.41B
Revenue Growth
-67.78%
P/S Ratio
132.71
Revenue / Employee
442.48M
Employees
19
Market Cap
1,115.70B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 8.61B -23.11B -72.85%
Dec 31, 2023 31.72B 994.76M 3.24%
Dec 31, 2022 30.73B 4.07B 15.28%
Dec 31, 2021 26.65B -1.98B -6.92%
Dec 31, 2020 28.63B 10.71B 59.79%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 308.10T
SK hynix 71.40T
LG Energy Solution 25.76T
Samsung Biologics 4,898.69B
Hyundai Motor Company 178.98T
KB Financial Group 14.93T
Celltrion 3,662.23B
Kia Corporation 109.25T
Revenue Rankings